Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients
  The goal of the ELDERCARE-AF trial was to assess the safety and efficacy of low-dose edoxaban among Japanese patients ≥80 years of age who had nonvalvular atrial fibrillation (AF) and in whom standard oral anticoagulants were not recommended.
• Mild Valvular Lesions and Long-Term CV Outcomes in Black Adults
  What are the associations of three mild valvular lesions (aortic sclerosis, trace or mild aortic regurgitation [AR], and trace or mild mitral regurgitation [MR]) with adverse cardiovascular (CV) events in Black adults?
• Text Messages to Improve Medication Adherence After ACS
  Does a text message-delivered cardiac education intervention improve medication adherence among patients after acute coronary syndrome (ACS)?
• Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial
  The goal of the REDUCE-IT trial was to assess the safety and benefit of icosapent ethyl compared with placebo in reducing cardiovascular (CV) events among patients with high triglycerides (TGs).
• Time-Restricted Eating May Lower CVD Risk For Older Breast Cancer Survivors
  Older breast cancer survivors with cardiometabolic risk factors who restrict food intake to eight hours during the weekday, followed by 16 hours of fasting, may lower their risk of cardiovascular disease after a few weeks, according to a research letter published May 17 in JACC: CardioOncology.